Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.07. | Mind Medicine Inc.: MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT) | 384 | Business Wire | - New patent covers MM120 ODT formulation and extends patent term to 2041- - Claims include pharmaceutical formulation, methods of manufacturing and methods of treatment for MM120 ODT-
Mind... ► Artikel lesen | |
28.06. | Mind Medicine Inc. - 8-K, Current Report | 10 | SEC Filings | ||
28.06. | Mind Medicine Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
28.06. | Mind Medicine to join Russell 2000 index | 3 | Seeking Alpha | ||
28.06. | Mind Medicine Inc.: MindMed to be Included in Russell 2000 and Russell 3000 Indexes | 214 | Business Wire | Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced... ► Artikel lesen | |
27.06. | Optimi Health Corp.: Optimi Health and Mind Medicine Australia Launch OptiMed Prescriber Portal for Australian Psychiatrists | 237 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 27, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-approved, GMP-compliant pharmaceutical... ► Artikel lesen | |
21.06. | Mind Medicine Inc.: MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference | 314 | Business Wire | Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced... ► Artikel lesen | |
20.06. | MindMed Completes End-of-Phase 2 Meeting With FDA For MM120 In GAD | 4 | RTTNews | ||
20.06. | Mind Medicine Inc. - 8-K, Current Report | 1 | SEC Filings | ||
20.06. | Mind Medicine: MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD) | 238 | Business Wire | -Aligned on requirements for Phase 3 clinical development of MM120 for the treatment of GAD- -Initiation of Phase 3 program remains on schedule to begin in second half of 2024-
Mind Medicine... ► Artikel lesen | |
11.06. | Mind Medicine Inc. - 8-K, Current Report | 11 | SEC Filings | ||
05.06. | RBC recommends buying MindMed amid psychedelic stocks sell-off | 34 | Seeking Alpha | ||
29.05. | Mind Medicine a new outperform at Baird on LSD-based asset for anxiety | 37 | Seeking Alpha | ||
28.05. | MNMD, NBIX and OCUL are among after hour movers | 13 | Seeking Alpha | ||
28.05. | Mind Medicine Inc.: MindMed to Participate in June Conferences | 253 | Business Wire | Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced... ► Artikel lesen | |
09.05. | Mind Medicine (MindMed) Inc.: New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US | 405 | Business Wire | -GAD Diagnosis Increases Healthcare Costs and Decreases Work Productivity and Health-Related Quality of Life- -People with Undiagnosed GAD Incur Even Higher Total Healthcare Costs than those Diagnosed... ► Artikel lesen | |
08.05. | Mind Medicine Inc. - 10-Q, Quarterly Report | 9 | SEC Filings | ||
08.05. | MindMed Reports First Quarter 2024 Financial Results and Business Updates | 587 | Business Wire | --Announced positive Phase 2b clinical trial results for MM120 in Generalized Anxiety Disorder (GAD), demonstrating clinically and statistically significant activity through 12 weeks after treatment--... ► Artikel lesen | |
06.05. | MindMed releases promising phase 2 data on LSD-related anxiety therapy | 14 | Seeking Alpha | ||
04.05. | MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York | 695 | Business Wire | -A single oral administration of MM120 100 µg met its primary and key secondary endpoints and maintained clinically and statistically significant HAM-A reductions compared to placebo at 12 weeks... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BARRICK GOLD | 16,386 | +0,04 % | KW 29 Gold verzeichnet Rekorde - dazu Goldaktien Barrick, Newmont, Franco Nevada, Alamos Gold | Goldaktien, Gold und EURUSD - Unser Wochenrückblick auf die 28. Kalenderwoche 2024. Zudem werfen wir wie gewohnt auch einen Blick auf die Silberpreisentwicklung. Und natürlich gehört auch die Goldpreisentwicklung... ► Artikel lesen | |
RIO TINTO | 59,73 | +0,90 % | Rio Tinto ADR Aktie: Waldbrände lösen Großspende aus | Ein führendes Bergbauunternehmen hat nach verheerenden Waldbränden in der Region Labrador West eine beträchtliche Spende geleistet. Insgesamt wurden 200.000 kanadische Dollar bereitgestellt, wovon 125.000... ► Artikel lesen | |
STANDARD LITHIUM | 1,222 | -1,29 % | Schock-News für Standard Lithium Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
NEWMONT | 43,000 | -0,06 % | Newmont-Aktie: Kurs legt zu (42,9178 €) | An der US-amerikanischen Börse liegt der Anteilsschein von Newmont aktuell im Plus. Das Papier kostete zuletzt 46,61 US-Dollar. Für das Wertpapier von Newmont steht gegenwärtig ein Kursplus 1,99 Prozent... ► Artikel lesen | |
ARCADIUM LITHIUM PLC CDIS | 3,140 | 0,00 % | Allkem Ldt. Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
GLENCORE | 5,131 | -0,08 % | Nifty partnership for Cyprium and Glencore: ASX-listed Cyprium Metals on Friday announced a commercial strategic partnership ... | ||
FIRST MAJESTIC SILVER | 5,360 | -0,45 % | Strong usecase for Silver!: "There is a very strong case for silver today" Andrew Williams Interview | ||
LYNAS RARE EARTHS | 3,758 | +0,94 % | LYNAS RARE EARTHS LIMITED: Change in substantial holding | ||
ROCK TECH LITHIUM | 1,010 | -0,59 % | Rock Tech Lithium paves way for cement-based revenue | ||
CAMECO | 41,460 | -0,40 % | Cameco (CCJ) Gears Up to Report Q2 Earnings: What to Expect | ||
WHEATON PRECIOUS METALS | 53,70 | 0,00 % | Wheaton Precious Metals Corp. (WPM): The Best Gold Stock According to Reddit and Robinhood? | ||
FREEPORT-MCMORAN | 41,415 | -0,06 % | Freeport-McMoRan-Aktie: Kurs heute nahezu konstant (41,1620 €) | CODE Das Wertpapier kostete zuletzt 44,69 US-Dollar. Der Kurs der Aktie von Freeport-McMoRan zeigt sich derzeit kaum verändert im Vergleich zu der Schlussnotierung vom Vortag. Zur Stunde steht nur ein... ► Artikel lesen | |
AMERICAN LITHIUM | 0,450 | +1,67 % | American Lithium Corp.: American Lithium Announces Financial and Operating Highlights for First Quarter Ended May 31, 2024 | VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) -- American Lithium Corp. ("American Lithium" or the "Company") (TSX-V:LI | Nasdaq:AMLI | Frankfurt:5LA1) is pleased to provide financial... ► Artikel lesen | |
NORILSK NICKEL | - | - | Nickel mit deutlicher Erholung: Russische Norilsk meldet deutlichen Rückgang der Nickelproduktion | ||
URANIUM ENERGY | 5,249 | -0,46 % | Erste Einbrüche...: Wochenrückblick KW 29-2024: Handelskonflikte und Unternehmenszahlen im Fokus! |